Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.
Level V
Where this comes from
- Record sourced from PubMed, PMID 16698750.
- Also identified by PMC identifier 1856230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evaluation of 5‐fluorouracil chemotherapy and survival, based on mismatch repair (MMR) status, indicates that patients with MMR proficient colorectal tumours benefit from 5‐fluorouracil treatment while patients with MMR deficient tumours do not
Medical subject headings
- Antimetabolites, Antineoplastic
- Colorectal Neoplasms
- Fluorouracil